CureVac (5CV.F)
€4.15 0%
to add to portfolio
AI Score
-
Alternative
3 -
Fundamental
10 -
Technical
6
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on CureVac, AI stock picks, stock alerts and much more.
5CV.F AI Stock Analysis
AI stock analysis for 5CV.F is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like CureVac (5CV.F) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
5CV.F Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of CureVac (5CV.F), currently trading at €4.15, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About 5CV.F
-
CureVac N.
-
Symbol
5CV.F
-
Market
XETRA
-
Industry
Biotechnology
-
Market Cap
930.9M
Similar Stocks
 |
BioMarin Pharmaceutical Inc. BM8.DE |
€63.52 0.9% |
5 |
 |
Exelixis EX9.DE |
€33.78 0.5% |
4 |
 |
BioNTech SE 22UA.F |
€120.2 1.5% |
4 |
 |
Novavax NVV1.F |
€8.89 6.9% |
2 |
 |
MorphoSys AG MOR.DE |
€67.25 0.7% |
3 |
News
5CV.F Alternative Data
News Mentions
Sign up to access
Twitter Followers
Sign up to access
Youtube Subscribers
Sign up to access
LinkedIn Followers
Sign up to access
Job Postings
Sign up to access
LinkedIn Employees
Sign up to access
Web Traffic
Sign up to access
Business Outlook
Sign up to access
5CV.F Financials
5CV.F Key Metrics
-
Total Revenue
€493.9M
-
Net Income
€338M
-
Earnings per Share
€0
-
Free cash flow
€350.8M
-
EBITDA
€375.2M
-
EBITDA Ratio
0.759715
-
Total Assets
€854.2M
5CV.F 2-year Revenue & Income
5CV.F 2-year Free Cash Flow
5CV.F Technicals
5CV.F SMA
5CV.F RSI
FAQ
What's the current price of CureVac (5CV.F) Stock?
The price of an CureVac (5CV.F) share is €4.15.
What's the market cap of CureVac?
The current market cap of CureVac is 930.9M.
Should I buy or sell 5CV.F?
CureVac shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, CureVac is better viewed as a hold or accumulate position while waiting for further developments.
Is CureVac a good investment?
The current analysis of CureVac's fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in CureVac's portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy CureVac (5CV.F) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for CureVac stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to CureVac (5CV.F) that investors often compare it to?
CureVac (5CV.F) is often compared to similar stocks such as BioMarin Pharmaceutical Inc., Exelixis, BioNTech SE, Novavax and MorphoSys AG.
What is the forecast for CureVac's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast CureVac's stock price to be around €4.22 in 2026. Starting from the current price of €4.15, this represents a 1.7% change in price, indicating a neutral outlook for the stock.
How to buy CureVac (5CV.F) Stock?
CureVac stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy CureVac shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.